| Literature DB >> 23026284 |
Sartaj S Sanghera1, Steven J Nurkin, Todd L Demmy.
Abstract
Specialized centers have reduced the adverse outcomes associated with esophagectomy in the last 2 decades and now report operative mortalities of less than 5%. With the expanding use of screening endoscopy, early invasive esophageal adenocarcinoma is diagnosed more commonly. As a result, more patients enjoy long-term survival after curative resection. Simultaneously, emerging evidence supports the equivalence of competing endoscopic therapies for treatment of very early cancers and benign diseases. Accordingly, surgical resection requires re-evaluation using enhanced parameters to enable more meaningful comparative outcome analyses. This article summarizes the current evidence and examines future directions regarding esophagectomy quality of life.Entities:
Mesh:
Year: 2012 PMID: 23026284 DOI: 10.1016/j.suc.2012.07.001
Source DB: PubMed Journal: Surg Clin North Am ISSN: 0039-6109 Impact factor: 2.741